Glanzmann's thrombasthenia diagnostic study of choice: Difference between revisions
Created page with "__NOTOC__ {{Glanzmann's thrombasthenia}} {{CMG}} {{AE}} {{OK}}, Niyousha Danesh, MD-MPH ==Overview== ==References== {{reflist|2}} Category:Disease [..." |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2]. | |||
== Diagnostic study of choice == | |||
There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2]. | |||
==References== | ==References== | ||
Revision as of 18:24, 20 November 2018
|
Glanzmann's thrombasthenia |
|
Differentiating Glanzmann's thrombasthenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glanzmann's thrombasthenia diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Glanzmann's thrombasthenia diagnostic study of choice |
|
FDA on Glanzmann's thrombasthenia diagnostic study of choice |
|
CDC on Glanzmann's thrombasthenia diagnostic study of choice |
|
Glanzmann's thrombasthenia diagnostic study of choice in the news |
|
Blogs on Glanzmann's thrombasthenia diagnostic study of choice |
|
Risk calculators and risk factors for Glanzmann's thrombasthenia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2], Niyousha Danesh, MD-MPH
Overview
There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].
Diagnostic study of choice
There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].